Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy-Reference-Cited by-同舟云学术

Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy

Published:2023 Issue:24 Volume:11 Page:7856-7866
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Arul Michael R.¹,Alahmadi Ibtihal²,Turro Daylin Gamiotea³,Ruikar Aditya¹²,Abdulmalik Sama²,Williams Justin T.³,Sanganahalli Basavaraju G.⁴,Liang Bruce T.⁵,Verma Rajkumar³^ORCID,Kumbar Sangamesh G.¹²⁶^ORCID

Affiliation:

1. Department of Orthopaedic Surgery, University of Connecticut Health, Farmington, CT, USA

2. Department of Biomedical Engineering, University of Connecticut, Storrs, CT, USA

3. Department of Neurosciences, UConn Health, Farmington, CT, USA

4. Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA

5. Calhuan Cardiology Centre, UConn Health, Farmington, CT, USA

6. Department of Materials Science and Engineering, University of Connecticut, Storrs, CT, USA

Abstract

Ischemic Stroke causes acute CNS disorders. This article represents an injectable liposomal nanoparticle formulation of 5-BDBD and Nile red for treatment of Ischemic Stroke.

Funder

National Institute of Biomedical Imaging and Bioengineering

National Institutes of Health

U.S. Army Medical Research Acquisition Activity

American Heart Association

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D3BM00951C

Reference91 articles.

1. S.Lahkar and M. K.Das , in Multifunctional Theranostic Nanomedicines in Cancer , Elsevier , 2021 , pp. 115–146

2. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

3. Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy

4. Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy;International Journal of Nanomedicine;2024-04